Jennifer Jarrett insider trades: Damora Therapeutics (DMRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jennifer reports to the SEC
and 4 more companies
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | DMRA | ↑ Buy | 12,500 | $20.23 | $253K | Direct | Sep 28, 2026 (3d) |
| Dec 17, 2025 | RCUS | ↓ Sell | 21,208 | $22.01 | $467K | Direct | Dec 18, 2025 (1d) |
| Nov 7, 2025 | RCUS | ↓ Sell10b5-1 | 50,291 | $18.97 | $954K | Direct | Nov 12, 2025 (5d) |
| Oct 8, 2025 | RCUS | ↓ Sell10b5-1 | 50,292 | $14.92 | $750K | Direct | Oct 8, 2025 (0d) |
| Mar 27, 2024 | RCUS | ↓ Sell10b5-1 | 11,551 | $17.55 | $203K | Direct | Mar 29, 2024 (2d) |
| Mar 18, 2024 | RCUS | ↓ Sell | 13,449 | $17.92 | $241K | Direct | Mar 20, 2024 (2d) |
| Feb 27, 2024 | RCUS | ↓ Sell10b5-1 | 58,625 | $20.09 | $1.2M | Direct | Feb 28, 2024 (1d) |
| Dec 22, 2023 | RCUS | ↓ Sell10b5-1 | 21,521 | $17.76 | $382K | Direct | Dec 26, 2023 (4d) |
| Sep 22, 2023 | RCUS | ↓ Sell10b5-1 | 21,369 | $19.99 | $427K | Direct | Sep 26, 2023 (4d) |
| Jul 28, 2023 | RCUS | ↓ Sell10b5-1 | 45,000 | $20.25 | $911K | Direct | Jul 31, 2023 (3d) |
| Jun 22, 2023 | RCUS | ↓ Sell10b5-1 | 12,437 | $19.12 | $238K | Direct | Jun 26, 2023 (4d) |
| Jun 16, 2023 | RCUS | ↓ Sell | 12,563 | $19.35 | $243K | Direct | Jun 16, 2023 (0d) |
| Mar 16, 2023 | RCUS | ↓ Sell | 8,729 | $16.81 | $147K | Direct | Mar 20, 2023 (4d) |
| Jan 27, 2023 | RCUS | ↓ Sell | 1,900 | $23.53 | $45K | Direct | Jan 30, 2023 (3d) |
| Dec 16, 2022 | RCUS | ↓ Sell | 16,482 | $30.75 | $507K | Direct | Dec 16, 2022 (0d) |
| Sep 16, 2022 | RCUS | ↓ Sell | 12,677 | $26.28 | $333K | Direct | Sep 20, 2022 (4d) |
| Jun 17, 2022 | RCUS | ↓ Sell | 12,695 | $21.45 | $272K | Direct | Jun 21, 2022 (4d) |
| Mar 16, 2022 | RCUS | ↓ Sell | 9,617 | $31.62 | $304K | Direct | Mar 18, 2022 (2d) |
| Dec 20, 2021 | RCUS | ↓ Sell | 34,822 | $41.48 | $1.4M | Direct | Dec 22, 2021 (2d) |
| Dec 17, 2021 | RCUS | ↓ Sell | 12,678 | $40.12 | $509K | Direct | Dec 20, 2021 (3d) |
| Sep 21, 2021 | RCUS | ↓ Sell | 47,500 | $35.35 | $1.7M | Direct | Sep 22, 2021 (1d) |
| Jun 17, 2021 | RCUS | ↓ Sell | 8,831 | $23.89 | $211K | Direct | Jun 21, 2021 (4d) |
| Jun 4, 2021 | RCUS | ↓ Sell | 1,044 | $24.91 | $26K | Direct | Jun 7, 2021 (3d) |
| Mar 16, 2021 | RCUS | ↓ Sell | 8,661 | $35.03 | $303K | Direct | Mar 18, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DMRA insiders
Open-market trades in the last 12 months
About Jennifer Jarrett's insider trades
Jennifer Jarrett is Director, President and CEO at Damora Therapeutics (DMRA). Since Mar 16, 2021, Jennifer has reported 1 open-market purchase worth $253K and 23 sales worth $11.8M on SEC Form 4. In the last 12 months: 1 buy ($253K) and 2 sales ($1.4M).
8 sales (43% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (40 filings), shares returned to the company (7 filings), shares withheld for taxes (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DMRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.